ClinicalTrials.gov
public full text
Public Domain
Phase I, Open Label Dose Escalation Study to Evaluate Safety of iHIVARNA-01 in Chronically HIV-infected Patients
The main purpose of the study is to evaluate the safety and to establish the recommended dose of iHIVARNA-01 as a new therapeutic vaccine against HIV
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Investigation of V520 in a HIV Vaccine Dose Refinement Study (V520-027)(TERMINATED)#883852
- COV-CHIM01: SARS-CoV-2 (COVID-19) Dose Finding Infection Study#1138700
- Safety and PK Multi-dose Study of TAF/EVG Vaginal Insert#881539
- Optimization of a Tenofovir Enema for HIV Prevention#867704
- Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine#868476
Record · ID 896037
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive